Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. |
| |
Authors: | Murat Eren Ozen Mehmet Yumru Haluk A Savas Neslihan Cansel Hasan Herken |
| |
Affiliation: | Department of Psychiatry, Gaziantep University Faculty of Medicine, Gaziantep, Turkey. |
| |
Abstract: | Neuroleptic malignant syndrome (NMS) is the rarest and most serious of the neuroleptic-induced movement disorders. We describe a case of neuroleptic malignant syndrome (NMS) associated with the use of ziprasidone. Although conventional neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs like ziprasidone may also be a cause. The patient is a 24-year-old male with a history of schizophrenia who developed signs and symptoms of NMS after 2 days of treatment with an 80-mg/day dose of orally administrated ziprasidone. This case is the earliest (second day of treatment) NMS due to ziprasidone reported in the literature. |
| |
Keywords: | |
|
|